Pure Global AI
Disease / condition

Metastatic Colorectal Cancer clinical trials

Free access to 467 studies10+ countriesUpdated daily86 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
467
Total trials
10+
Countries
10+
Sponsors
86
Recruiting
By phase
Phase 2219
N/A99
Phase 350
Phase 141
Early Phase 133
By status
Completed201
Recruiting86
Unknown50
Not yet recruit...42
Terminated41
Top countries
China72
United States of America58
France38
Italy30
Spain16
Top sponsors
Amgen13
Sun Yat-sen Univer...10
Spanish Cooperativ...9
Bayer7
Gruppo Oncologico ...7
Recent trials
Latest clinical trials for Metastatic Colorectal Cancer
Combination Therapy for BRAF-V600E Metastatic CRCm
Vall d'Hebron Institute of Onc...
NCT06411600Not yet recr...
Phase
Phase 2
A Study of SC-0191 in Subjects With Metastatic Colorectal Cancer
Tianshu Liu · China
NCT06363552Not yet recr...
Phase
Phase 2
Irinotecan, TAS-102 Plus Bevacizumab as a Third-Line or Beyond Therapy in mCRC Patients
Cancer Institute and Hospital,... · China
NCT06403709Recruitment ...
Phase
Phase 2
Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer
West China Hospital
NCT06341296Not yet recr...
Phase
Phase 2
Exploratory Study of Irinotecan Liposomes in Maintenance Therapy of Metastatic Colorectal Cancer
West China Hospital
NCT06341309Not yet recr...
Phase
Phase 1/2
Oral Inulin in Combination With Fruquintinib Plus Sintilimab as Third- or Further-line Treatment in Metastatic Colorectal Cancer
Wuhan Union Hospital, China · China
NCT06347198Recruiting
Phase
Phase 1
Second-line Treatment of Metastatic Colorectal Cancer
Qilu Hospital of Shandong Univ... · China
NCT06242067Recruiting
Phase
Phase 2
Sacituzumab Govitecan in Metastatic Colorectal Cancer
University Hospital Heidelberg · Germany
NCT06243393Not yet recr...
Phase
Phase 2/3
Adebrelimab Plus Cetuximab and Chemotherapy for Patients With RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer
The First Affiliated Hospital ... · China
NCT06231017Recruiting
Phase
Phase 2
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Amgen
NCT06252649Not yet recr...
Phase
Phase 3
Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer
Shanghai Zhongshan Hospital · China
NCT06225622Recruiting
Phase
Phase 1
MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases
Shengjing Hospital · China
NCT06208397Recruiting
Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)
National Cancer Institute (NCI... · United States of America
NCT06149481Not yet recr...
Phase
Phase 1/2
Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver Metastasis
Alethia Biotherapeutics · Canada
NCT06225843Recruiting
Phase
Phase 2
A Real-World Study to Learn More About the Order of Different Treatments and Their Effects in People With Metastatic Colorectal Cancer Receiving Their Third and Fourth Line of Treatment
Bayer
NCT06137170Not yet recr...
Sulfasalazine in Patients With Metastatic Colorectal Cancer
Tanta University · Egypt
NCT06134388Recruiting
Phase
Phase 3
Clinical Study of Fruquintinib Combined With Raltitrexed in the Treatment of Metastatic Colorectal Cancer
The First Affiliated Hospital ... · China
NCT06118762Recruiting
Phase
Phase 4
LB-100 (PP2A Inhibitor) and Azenosertib (WEE1 Inhibitor) in Metastatic Colorectal Cancer Patients
The Netherlands Cancer Institu...
NCT06109883Not yet recr...
Phase
Phase 1
Envafolimab Combined With Trifluridine/Tipiracil and Bevacizumab in the Treatment of Refractory mCRC.
The First Affiliated Hospital ... · China
NCT06060704Recruiting
Phase
Phase 2
Nitazoxanide in Patients With Metastatic Colorectal Cancer
Tanta University · Egypt
NCT06049901Recruiting
Phase
Phase 3
About this profile

Access comprehensive clinical trial information for Metastatic Colorectal Cancer through Pure Global AI's free database. This collection includes 467 clinical trials across multiple phases including Phase 2, N/A, Phase 3. Currently, 86 trials are actively recruiting participants.

Research for Metastatic Colorectal Cancer is being conducted in China, United States of America, France and 7+ other countries. Leading sponsors include Amgen and Sun Yat-sen University. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 467 clinical trials studying Metastatic Colorectal Cancer, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Amgen, Sun Yat-sen University, Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD), among others.